(Q53142048)

English

Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.

scientific article published on 13 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Crohn's disease

1 reference

based on heuristic

inferred from title

Takayuki Matsumoto

16

object named as

Takayuki Matsumoto

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

author name string

Koji Yoshida

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Ken Fukunaga

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Hiroki Ikeuchi

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Koji Kamikozuru

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Nobuyuki Hida

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Yoshio Ohda

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Yoko Yokoyama

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Masaki Iimuro

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Naohisa Takeda

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Kyoichi Kato

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Risa Kikuyama

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Kazuko Nagase

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Kazutoshi Hori

13

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Shiro Nakamura

14

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Hiroto Miwa

15

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

publication date

13 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

18

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

1617-1623

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

What is the optimal therapy for Crohn's disease: step-up or top-down?

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Risk factors for surgery and postoperative recurrence in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Infliximab prevents Crohn's disease recurrence after ileal resection

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21928

21 January 2018

Identifiers

10.1002/IBD.21928

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22081474

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53142048&oldid=1569442382"